Cancer Research Audrey Hepburn  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 2306, March 1, 2007. doi: 10.1158/0008-5472.CAN-06-3824
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patenaude, A.
Right arrow Articles by C.-Gaudreault, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patenaude, A.
Right arrow Articles by C.-Gaudreault, R.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Alexandre Patenaude1, Réna G. Deschesnes1, Jean L.C. Rousseau1, Éric Petitclerc1, Jacques Lacroix1, Marie-France Côté1 and René C.-Gaudreault1,2

1 Unité de Biotechnologie et de Bioingénierie, CHUQ, Hôpital Saint-François d'Assise and 2 Département de Médecine, Faculté de Médecine, Université Laval, Québec, Canada

Requests for reprints: René C.-Gaudreault, or Alexandre Patenaude, Unité de Biotechnologie et de Bioingénierie, Centre de recherche, CHUQ, Hôpital Saint-François d'Assise, Québec, Québec, Canada G1L 3L5. Phone: 418-525-4444, ext. 52363 or 53401; Fax: 418-525-4372; E-mail: rene.c-gaudreault{at}crsfa.ulaval.ca, or alexandre.patenaude{at}crchul.ulaval.ca.

Chloroethylureas (CEU) are soft alkylating agents that covalently bind to ß-tubulin (ßTAC) and affect microtubule polymerization dynamics. Herein, we report the identification of a CEU subset and its corresponding oxazolines, which induce cell growth inhibition, apoptosis, and microtubule disruption without alkylating ß-tubulin (N-ßTAC). Both ßTAC and N-ßTAC trigger the collapse of mitochondrial potential ({Delta}{Psi}m) and modulate reactive oxygen species levels, following activation of intrinsic caspase-8 and caspase-9. Experiments using human fibrosarcoma HT1080 respiratory-deficient cells ({rho}0) and uncoupler of the mitochondrial respiratory chain (MRC) showed that ßTAC and N-ßTAC impaired the MRC. {rho}0 cells displayed an increased sensitivity toward N-ßTAC as compared with {rho}+ cells but, in contrast, were resistant to ßTAC or classic chemotherapeutics, such as paclitaxel. Oxazoline-195 (OXA-195), an N-ßTAC derivative, triggered massive swelling of isolated mitochondria. This effect was insensitive to cyclosporin A and to Bcl-2 addition. In contrast, adenine nucleotide translocator (ANT) antagonists, bongkrekic acid or atractyloside, diminished swelling induced by OXA-195. The antiproliferative activities of the N-ßTACs CEU-025 and OXA-152 were markedly decreased in the presence of atractyloside. Conversely, pretreatment with cyclosporin A enhanced growth inhibition induced by ßTAC and N-ßTAC. One of the proteins alkylated by N-ßTAC was identified as the voltage-dependent anion channel isoform-1, an ANT partner. Our results suggest that ßTAC and N-ßTAC, despite their common ability to affect the microtubule network, trigger different cytotoxic mechanisms in cancer cells. The role of mitochondria in these mechanisms and the potential of N-ßTAC as a new therapeutic approach for targeting hypoxia-resistant cells are discussed. [Cancer Res 2007;67(5):2306–16]




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. R. Khawaja, M. Carre, H. Kovacic, M. A. Esteve, and D. Braguer
Patupilone-Induced Apoptosis Is Mediated by Mitochondrial Reactive Oxygen Species through Bim Relocalization to Mitochondria
Mol. Pharmacol., October 1, 2008; 74(4): 1072 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. S. Li, J. C. Morales, A. Hwang, M. W. Wagner, and D. A. Boothman
DNA Mismatch Repair-dependent Activation of c-Abl/p73{alpha}/GADD45{alpha}-mediated Apoptosis
J. Biol. Chem., August 1, 2008; 283(31): 21394 - 21403.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.